Avinger (AVGR) Competitors $0.47 0.00 (0.00%) As of 03/28/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AVGR vs. AEMD, CHEK, AMIX, NUWE, SINT, CTCX, NAOV, HSCS, TNON, and GCTKShould you be buying Avinger stock or one of its competitors? The main competitors of Avinger include Aethlon Medical (AEMD), Check-Cap (CHEK), Autonomix Medical (AMIX), Nuwellis (NUWE), Sintx Technologies (SINT), Carmell (CTCX), NanoVibronix (NAOV), Heart Test Laboratories (HSCS), Tenon Medical (TNON), and GlucoTrack (GCTK). These companies are all part of the "medical equipment" industry. Avinger vs. Aethlon Medical Check-Cap Autonomix Medical Nuwellis Sintx Technologies Carmell NanoVibronix Heart Test Laboratories Tenon Medical GlucoTrack Avinger (NASDAQ:AVGR) and Aethlon Medical (NASDAQ:AEMD) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, community ranking, dividends, earnings, analyst recommendations, profitability, media sentiment, institutional ownership and risk. Does the media prefer AVGR or AEMD? In the previous week, Aethlon Medical had 5 more articles in the media than Avinger. MarketBeat recorded 5 mentions for Aethlon Medical and 0 mentions for Avinger. Aethlon Medical's average media sentiment score of 0.77 beat Avinger's score of 0.00 indicating that Aethlon Medical is being referred to more favorably in the news media. Company Overall Sentiment Avinger Neutral Aethlon Medical Positive Is AVGR or AEMD more profitable? Aethlon Medical has a net margin of 0.00% compared to Avinger's net margin of -261.06%. Aethlon Medical's return on equity of -153.96% beat Avinger's return on equity.Company Net Margins Return on Equity Return on Assets Avinger-261.06% -5,527.11% -123.25% Aethlon Medical N/A -153.96%-109.13% Which has preferable earnings & valuation, AVGR or AEMD? Aethlon Medical has lower revenue, but higher earnings than Avinger. Aethlon Medical is trading at a lower price-to-earnings ratio than Avinger, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvinger$7.26M0.22-$18.32M-$11.06-0.04Aethlon Medical$570K9.21-$12.21M-$1.58-0.23 Do analysts prefer AVGR or AEMD? Aethlon Medical has a consensus target price of $7.00, indicating a potential upside of 1,828.37%. Given Aethlon Medical's stronger consensus rating and higher possible upside, analysts plainly believe Aethlon Medical is more favorable than Avinger.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avinger 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Aethlon Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk & volatility, AVGR or AEMD? Avinger has a beta of 1.09, indicating that its share price is 9% more volatile than the S&P 500. Comparatively, Aethlon Medical has a beta of 1.8, indicating that its share price is 80% more volatile than the S&P 500. Do insiders & institutionals believe in AVGR or AEMD? 18.3% of Avinger shares are owned by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are owned by institutional investors. 42.8% of Avinger shares are owned by insiders. Comparatively, 1.1% of Aethlon Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the MarketBeat Community prefer AVGR or AEMD? Avinger received 172 more outperform votes than Aethlon Medical when rated by MarketBeat users. Likewise, 56.22% of users gave Avinger an outperform vote while only 50.92% of users gave Aethlon Medical an outperform vote. CompanyUnderperformOutperformAvingerOutperform Votes39356.22% Underperform Votes30643.78% Aethlon MedicalOutperform Votes22150.92% Underperform Votes21349.08% SummaryAethlon Medical beats Avinger on 12 of the 18 factors compared between the two stocks. Remove Ads Get Avinger News Delivered to You Automatically Sign up to receive the latest news and ratings for AVGR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AVGR vs. The Competition Export to ExcelMetricAvingerSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.57M$4.35B$5.62B$7.73BDividend YieldN/A48.03%5.33%4.02%P/E Ratio-0.0428.2823.5418.59Price / Sales0.2248.80371.7888.87Price / CashN/A51.0838.1734.64Price / Book-0.106.056.824.11Net Income-$18.32M$67.64M$3.20B$247.18M7 Day PerformanceN/A-6.40%-5.42%-3.93%1 Month PerformanceN/A-5.25%-0.14%-6.33%1 Year Performance-84.70%9.21%7.96%-1.93% Avinger Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AVGRAvingerN/A$0.47flatN/AN/A$1.57M$7.26M-0.0470AEMDAethlon Medical2.9055 of 5 stars$0.43-0.2%$7.00+1,531.7%-78.2%$6.20M$570,000.00-0.2710Analyst ForecastShort Interest ↓CHEKCheck-Cap1.0482 of 5 stars$0.91+3.0%N/A-74.6%$5.30MN/A-0.3080Short Interest ↓Gap UpAMIXAutonomix Medical3.5495 of 5 stars$2.03+2.0%$28.00+1,279.3%-97.0%$5MN/A-0.161Short Interest ↓Gap UpNUWENuwellis3.5892 of 5 stars$1.14+0.9%$17.00+1,391.2%-92.2%$4.99M$8.74M-0.0170Short Interest ↓SINTSintx Technologies1.1254 of 5 stars$2.89-3.7%N/A-72.0%$3.88M$1.64M-0.0640Short Interest ↓Gap DownCTCXCarmell0.9544 of 5 stars$0.18-4.1%N/A-95.2%$3.81M$32,839.000.0014Gap DownNAOVNanoVibronix0.9374 of 5 stars$4.25-3.2%N/A-61.9%$3.37M$3.29M-3.4620HSCSHeart Test Laboratories2.9704 of 5 stars$2.96+1.7%$13.00+339.2%-75.6%$3.20M$14,700.00-0.3710TNONTenon Medical1.6093 of 5 stars$0.98-2.2%$5.50+462.3%+160.0%$3.07M$3.32M-0.048High Trading VolumeGCTKGlucoTrack1.8796 of 5 stars$0.27-9.5%N/A-99.4%$2.81MN/A0.005News CoverageGap UpHigh Trading Volume Remove Ads Related Companies and Tools Related Companies Aethlon Medical Alternatives Check-Cap Alternatives Autonomix Medical Alternatives Nuwellis Alternatives Sintx Technologies Alternatives Carmell Alternatives NanoVibronix Alternatives Heart Test Laboratories Alternatives Tenon Medical Alternatives GlucoTrack Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AVGR) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avinger, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avinger With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AVGR Stock Free AVGR Stock Alerts